[Initial results of high-dosage hyaluromidase long-term therapy ("Hylase" Dessau) in dermatology].
D002986:Clinical Trials as Topic; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000008:administration & dosage* / Q000627:therapeutic use; D007627:Keloid / Q000188:drug therapy*; D012594:Scleroderma, Localized / Q000188:drug therapy*; D012595:Scleroderma, Systemic / Q000188:drug therapy*
D006821:Hyaluronoglucosaminidase
Erste Erfahrungen mit hochdosierter Hyaluronidase-Langzeittherapie ("Hylase" Dessau) in der Dermatologie.